Suppr超能文献

用于基因治疗的神经疾病大型动物模型。

Large animal models of neurological disorders for gene therapy.

作者信息

Gagliardi Christine, Bunnell Bruce A

机构信息

Tulane National Primate Research Center, Covington, LA 70433-8915, USA.

出版信息

ILAR J. 2009;50(2):128-43. doi: 10.1093/ilar.50.2.128.

Abstract

he development of therapeutic interventions for genetic disorders and diseases that affect the central nervous system (CNS) has proven challenging. There has been significant progress in the development of gene therapy strategies in murine models of human disease, but gene therapy outcomes in these models do not always translate to the human setting. Therefore, large animal models are crucial to the development of diagnostics, treatments, and eventual cures for debilitating neurological disorders. This review focuses on the description of large animal models of neurological diseases such as lysosomal storage diseases, Parkinsons disease, Huntingtons disease, and neuroAIDS. The review also describes the contributions of these models to progress in gene therapy research.

摘要

事实证明,开发针对影响中枢神经系统(CNS)的遗传疾病和病症的治疗干预措施具有挑战性。在人类疾病的小鼠模型中,基因治疗策略的开发取得了重大进展,但这些模型中的基因治疗结果并不总是能转化到人类环境中。因此,大型动物模型对于衰弱性神经疾病的诊断、治疗及最终治愈的发展至关重要。本综述着重描述神经疾病的大型动物模型,如溶酶体贮积病、帕金森病、亨廷顿病和神经艾滋病。该综述还描述了这些模型对基因治疗研究进展的贡献。

相似文献

1
Large animal models of neurological disorders for gene therapy.
ILAR J. 2009;50(2):128-43. doi: 10.1093/ilar.50.2.128.
2
Delivering Hematopoietic Stem Cell Gene Therapy Treatments for Neurological Lysosomal Diseases.
ACS Chem Neurosci. 2019 Jan 16;10(1):18-20. doi: 10.1021/acschemneuro.8b00408. Epub 2018 Aug 23.
4
Gene therapy for lysosomal storage disorders.
Pediatr Endocrinol Rev. 2013 Nov;11 Suppl 1:99-109.
5
Gene therapy for lysosomal storage disorders.
Expert Opin Biol Ther. 2001 Sep;1(5):857-67. doi: 10.1517/14712598.1.5.857.
7
Development and applications of non-HIV-based lentiviral vectors in neurological disorders.
Curr Gene Ther. 2008 Dec;8(6):406-18. doi: 10.2174/156652308786848030.
8
Gene therapy for the central nervous system in the lysosomal storage disorders.
Neurol Clin. 2002 Aug;20(3):879-901. doi: 10.1016/s0733-8619(02)00010-5.
9
Gene therapy for lysosomal storage diseases: progress, challenges and future prospects.
Curr Pharm Des. 2011;17(24):2558-74. doi: 10.2174/138161211797247578.
10
CNS-directed gene therapy for lysosomal storage diseases.
Acta Paediatr. 2008 Apr;97(457):22-7. doi: 10.1111/j.1651-2227.2008.00660.x.

引用本文的文献

1
Large- and Small-Animal Studies of Safety, Pharmacokinetics, and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target Organs.
ACS Pharmacol Transl Sci. 2024 Mar 21;7(11):3439-3451. doi: 10.1021/acsptsci.4c00068. eCollection 2024 Nov 8.
4
Animal models for metabolic, neuromuscular and ophthalmological rare diseases.
Nat Rev Drug Discov. 2013 Apr;12(4):287-305. doi: 10.1038/nrd3831. Epub 2013 Mar 15.
5
Towards human central nervous system in vitro models for preclinical research: strategies for 3D neural cell culture.
BMC Proc. 2011 Nov 22;5 Suppl 8(Suppl 8):P53. doi: 10.1186/1753-6561-5-S8-P53. eCollection 2011.
6
7
Gene therapy in large animal models of human genetic diseases. Introduction.
ILAR J. 2009;50(2):107-11. doi: 10.1093/ilar.50.2.107.

本文引用的文献

1
A population-average MRI-based atlas collection of the rhesus macaque.
Neuroimage. 2009 Mar 1;45(1):52-9. doi: 10.1016/j.neuroimage.2008.10.058. Epub 2008 Nov 14.
2
Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery.
Exp Neurol. 2009 Jan;215(1):153-9. doi: 10.1016/j.expneurol.2008.10.004. Epub 2008 Oct 25.
3
Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy.
Mol Genet Metab. 2008 Nov;95(3):142-51. doi: 10.1016/j.ymgme.2008.07.003. Epub 2008 Aug 15.
5
Alpha-mannosidosis.
Orphanet J Rare Dis. 2008 Jul 23;3:21. doi: 10.1186/1750-1172-3-21.
6
Mechanisms of neurodegeneration in Huntington's disease.
Eur J Neurosci. 2008 Jun;27(11):2803-20. doi: 10.1111/j.1460-9568.2008.06310.x.
7
Towards a transgenic model of Huntington's disease in a non-human primate.
Nature. 2008 Jun 12;453(7197):921-4. doi: 10.1038/nature06975. Epub 2008 May 18.
8
Huntington's disease: from pathology and genetics to potential therapies.
Biochem J. 2008 Jun 1;412(2):191-209. doi: 10.1042/BJ20071619.
9
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease.
Neurology. 2008 May 20;70(21):1980-3. doi: 10.1212/01.wnl.0000312381.29287.ff. Epub 2008 Apr 9.
10
Symptomatic treatment of Huntington disease.
Neurotherapeutics. 2008 Apr;5(2):181-97. doi: 10.1016/j.nurt.2008.01.008.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验